The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-3-(1-(5-bromo-4-(4-chlorophenyl)oxazol-2-yl)propoxy)-2,6-difluorobenzamide ID: ALA3098790
PubChem CID: 66575005
Max Phase: Preclinical
Molecular Formula: C19H14BrClF2N2O3
Molecular Weight: 471.69
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCC(Oc1ccc(F)c(C(N)=O)c1F)c1nc(-c2ccc(Cl)cc2)c(Br)o1
Standard InChI: InChI=1S/C19H14BrClF2N2O3/c1-2-12(27-13-8-7-11(22)14(15(13)23)18(24)26)19-25-16(17(20)28-19)9-3-5-10(21)6-4-9/h3-8,12H,2H2,1H3,(H2,24,26)
Standard InChI Key: NKBKZEWTZNJEDA-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
21.5716 -11.6387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5705 -12.4583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2785 -12.8672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9882 -12.4578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9853 -11.6351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2767 -11.2299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8638 -11.2303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8636 -10.4131 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.1562 -11.6391 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.8624 -12.8663 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
22.2743 -10.4127 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
23.6915 -11.2239 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.4007 -11.6298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1069 -11.2186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8563 -11.5529 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.1909 -10.4104 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.9896 -10.2373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3995 -10.9444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3186 -9.4918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1323 -9.4052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4625 -8.6585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9801 -7.9979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1637 -8.0887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8372 -8.8356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2125 -11.0272 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
27.3093 -7.2499 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
24.4038 -12.4470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6977 -12.8583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 2 0
7 9 1 0
2 10 1 0
6 11 1 0
5 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 18 1 0
17 16 1 0
16 14 2 0
17 18 2 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
17 19 1 0
18 25 1 0
22 26 1 0
13 27 1 0
27 28 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 471.69Molecular Weight (Monoisotopic): 469.9844AlogP: 5.66#Rotatable Bonds: 6Polar Surface Area: 78.35Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 10.96CX Basic pKa: ┄CX LogP: 4.89CX LogD: 4.89Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.50Np Likeness Score: -0.98
References 1. Stokes NR, Baker N, Bennett JM, Chauhan PK, Collins I, Davies DT, Gavade M, Kumar D, Lancett P, Macdonald R, Macleod L, Mahajan A, Mitchell JP, Nayal N, Nayal YN, Pitt GR, Singh M, Yadav A, Srivastava A, Czaplewski LG, Haydon DJ.. (2014) Design, synthesis and structure-activity relationships of substituted oxazole-benzamide antibacterial inhibitors of FtsZ., 24 (1): [PMID:24287381 ] [10.1016/j.bmcl.2013.11.002 ]